- SEK14.35bn
- SEK28.17bn
- SEK16.04bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.08 | ||
| PEG Ratio (f) | 0.44 | ||
| EPS Growth (f) | 46.69% | ||
| Dividend Yield (f) | 1.95% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.1 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.21 | ||
| Price to Sales | 0.83 | ||
| EV to EBITDA | 8.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.01% | ||
| Return on Equity | 16.93% | ||
| Operating Margin | 9.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 11,478 | 12,635 | 13,312 | 14,195 | 16,039 | 19,540 | 26,561.5 | 7.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -3 | +0.05 | +22.85 | +42.14 | +17.75 | +9.94 | +52.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ambea AB (publ) is a Sweden‑based care company primarily engaged in the health and social care services industry. The Company scope includes offering elderly care, disability care, and psychosocial support services through a portfolio of specialized operating entities. The Company’s primary focus is the provision of care services delivered through residential facilities, home‑based care, and support services for individuals with long‑term care needs. Ambea’s services cover several care segments, including residential nursing homes for older adults, home care, disability support for children, adolescents, and adults, and psychosocial care for individuals with mental health and social support needs. The Company operates across all four Nordic countries. The Swedish operations comprise the brands Nytida (social care), Vardaga (elderly care), and Klara (staffing solutions). Other operating segments include Stendi (Norway), Altiden (Denmark), Validia (Finland).
Directors
- Patricia Rodriguez DRC
- Charalampos Kalpakas DRC
- Magnus Sallstrom DRC
- Ingvild Kristiansen MDR (53)
- Mark Jensen PRE (55)
- Benno Eliasson CFO (61)
- Yrjoe Naerhinen NEC (57)
- Fredrik von Malmborg MDR (59)
- Susanne Sjoberg MDR (56)
- Erika Enestad OTH (44)
- Elin Delvert DHR (55)
- Linda Johansson DRC
- Laura Ammala MDR (49)
- Trine Mottlau MDR (67)
- Last Annual
- December 31st, 2025
- Last Interim
- September 30th, 2026
- Incorporated
- July 9th, 1993
- Public Since
- March 31st, 2017
- No. of Shareholders
- 8,216
- No. of Employees
- 18,206
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 74,823,766
- Address
- Rontgenvagen 3D, Box 1565, SOLNA, 171 29
- Web
- https://www.ambea.se/
- Phone
- +46 857870000
- Contact
- Susanne Vogt
- Auditors
- Ernst & Young AB
Latest News for AMBEA
Upcoming Events for AMBEA
Q4 2026 Ambea publ AB Earnings Release
Q1 2027 Ambea publ AB Earnings Release
Similar to AMBEA
Attendo AB (publ)
OMX Nordic Exchange Stockholm
Medicover AB
OMX Nordic Exchange Stockholm
Prostatype Genomics AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 18:14 UTC, shares in Ambea publ AB are trading at SEK191.80. This share price information is delayed by 15 minutes.
Shares in Ambea publ AB last closed at SEK191.80 and the price had moved by +54.3% over the past 365 days. In terms of relative price strength the Ambea publ AB share price has outperformed the FTSE Global All Cap Index by +34.36% over the past year.
The overall consensus recommendation for Ambea publ AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ambea publ AB dividend yield is 1.38% based on the trailing twelve month period.
Last year, Ambea publ AB paid a total dividend of SEK2.65, and it currently has a trailing dividend yield of 1.38%. We do not have any data on when Ambea publ AB is to next pay dividends.
We do not have data on when Ambea publ AB is to next pay dividends. The historic dividend yield on Ambea publ AB shares is currently 1.38%.
To buy shares in Ambea publ AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK191.80, shares in Ambea publ AB had a market capitalisation of SEK14.35bn.
Here are the trading details for Ambea publ AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: AMBEA
Based on an overall assessment of its quality, value and momentum Ambea publ AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ambea publ AB is SEK212.00. That is 10.53% above the last closing price of SEK191.80.
Analysts covering Ambea publ AB currently have a consensus Earnings Per Share (EPS) forecast of SEK9.41 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ambea publ AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +23.63%.
As of the last closing price of SEK191.80, shares in Ambea publ AB were trading +28.42% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ambea publ AB PE ratio based on its reported earnings over the past 12 months is 14.08. The shares last closed at SEK191.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ambea publ AB's management team is headed by:
- Patricia Rodriguez - DRC
- Charalampos Kalpakas - DRC
- Magnus Sallstrom - DRC
- Ingvild Kristiansen - MDR
- Mark Jensen - PRE
- Benno Eliasson - CFO
- Yrjoe Naerhinen - NEC
- Fredrik von Malmborg - MDR
- Susanne Sjoberg - MDR
- Erika Enestad - OTH
- Elin Delvert - DHR
- Linda Johansson - DRC
- Laura Ammala - MDR
- Trine Mottlau - MDR